INTRODUCTION:

Welcome to the “Benefit-Risk Assessment in Pharmacovigilance Master Class 2024”, A comprehensive two-day training designed to provide in-depth insights into the latest trends and methodologies shaping benefit-risk assessment within the pharmaceutical industry. This masterclass aims to equip participants with the essential knowledge and practical skills needed to navigate the complexities of benefit-risk evaluation throughout the lifecycle of medicinal products.

KEY BENEFITS:

By participating in this masterclass, attendees will gain a thorough understanding of benefit-risk frameworks, methodologies, and regulatory expectations. The training offers a unique opportunity to enhance proficiency in performing hands-on benefit-risk analyses, ensuring participants are well-prepared to critically evaluate results and make informed decisions. Whether you are involved in drug safety, pharmacovigilance, regulatory affairs, or clinical research, this masterclass will empower you to optimize
benefit-risk balance.

WHO SHOULD ATTEND:

● Drug safety and pharmacovigilance professionals
● Safety evaluation experts
● Professionals involved in periodic safety reporting
● Experts in risk management planning and development of formal Risk Management Plans/REMS
● Medical writers.
● Regulatory strategy and regulatory affairs professionals.
● Clinical research experts.
● Medical Affairs professionals.